Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Precigen stock

Learn how to easily invest in Precigen stock.

Precigen Inc is a biotechnology business based in the US. Precigen shares (PGEN) are listed on the NASDAQ and all prices are listed in US Dollars. Precigen employs 423 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Precigen

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – PGEN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Precigen stock price (NASDAQ: PGEN)

Use our graph to track the performance of PGEN stocks over time.

Precigen shares at a glance

Information last updated 2022-01-17.
Latest market close$2.81
52-week range$3.02 - $9.89
50-day moving average $3.86
200-day moving average $5.55
Wall St. target price$12.20
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.57

Buy Precigen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
M1 Finance
Free 1-year trial of M1 Plus
when you sign up for M1 Finance
Invest in your favorite stocks or in curated portfolios with automatic rebalancing.
SoFi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in most equities.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$10 of crypto
Open an account with access to crypto
A platform built for all kinds of traders and all styles of trading
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stash Invest
Stocks, ETFs
$1 per month
Add at least $5 to your Invest account
Stash is more than an investment app. You’ll have access to tools that can help you become a confident investor.
Stocks, ETFs, Cryptocurrency
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $300, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Precigen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Precigen price performance over time

Historical closes compared with the close of $2.81 from 2022-01-21

1 week (2022-01-13) -8.77%
1 month (2021-12-22) -29.40%
3 months (2021-10-22) -38.78%
6 months (2021-07-23) -48.06%
1 year (2021-01-22) -69.49%
2 years (2020-01-24) -50.00%
3 years (2019-01-24) 7.85
5 years (2017-01-24) 21.65

Precigen financials

Revenue TTM $99 million
Gross profit TTM $6 million
Return on assets TTM -16.49%
Return on equity TTM -117.4%
Profit margin -109.91%
Book value $0.64
Market capitalisation $667.8 million

TTM: trailing 12 months

Precigen share dividends

We're not expecting Precigen to pay a dividend over the next 12 months.

Precigen share price volatility

Over the last 12 months, Precigen's shares have ranged in value from as little as $3.02 up to $9.8889. A popular way to gauge a stock's volatility is its "beta".

PGEN.US volatility(beta: 2.27)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Precigen's is 2.2722. This would suggest that Precigen's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Precigen overview

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch inducible gene switch that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc.

Frequently asked questions

What percentage of Precigen is owned by insiders or institutions?
Currently 11.833% of Precigen shares are held by insiders and 67.473% by institutions.
How many people work for Precigen?
Latest data suggests 423 work at Precigen.
When does the fiscal year end for Precigen?
Precigen's fiscal year ends in December.
Where is Precigen based?
Precigen's address is: 20374 Seneca Meadows Parkway, Germantown, MD, United States, 20876
What is Precigen's ISIN number?
Precigen's international securities identification number is: US74017N1054
What is Precigen's CUSIP number?
Precigen's Committee on Uniform Securities Identification Procedures number is: 46122T102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site